{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T06:16:18Z","timestamp":1772691378754,"version":"3.50.1"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,12,11]]},"DOI":"10.7759\/cureus.50313","type":"journal-article","created":{"date-parts":[[2023,12,11]],"date-time":"2023-12-11T12:01:31Z","timestamp":1702296091000},"source":"Crossref","is-referenced-by-count":3,"title":["Efficacy and Safety of Brivaracetam in Persons With Epilepsy in a Real-World Setting: A Prospective, Non-Interventional Study"],"prefix":"10.7759","author":[{"given":"Fowzia","family":"Siddiqui","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bashir  A","family":"Soomro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mazhar","family":"Badshah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ehsan  U","family":"Rehman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahsan","family":"Numan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amer","family":"Ikram","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad Wazir Ali","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sajjad","family":"Ali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Husnain","family":"Hashim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jawwad-us","family":"Salam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asad","family":"Akram","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad","family":"Irfan Hashmat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shahid","family":"Iqbal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad","family":"Zeeshan Javed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. Zafar","family":"Iqbal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atif","family":"Maqsood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Assadullah","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neeta","family":"Maheshwary","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad Athar","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"Epilepsy Foundation. What is epilepsy?. (2014). Accessed: December 22, 2019: https:\/\/www.epilepsy.com\/learn\/about-epilepsy-basics\/what-epilepsy."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1167.2011.03051.x","article-title":"The causes of epilepsy: changing concepts of etiology of epilepsy over the past 150 years","volume":"52","author":"Shorvon SD","year":"2011","unstructured":"Shorvon SD. The causes of epilepsy: changing concepts of etiology of epilepsy over the past 150 years. Epilepsia. 2011, 52:1033-44. 10.1111\/j.1528-1167.2011.03051.x","journal-title":"Epilepsia"},{"key":"ref3","unstructured":"World Health Organization. Epilepsy. (2019). Accessed: December 22, 2019: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/epilepsy."},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1111\/epi.13670","article-title":"Operational classification of seizure types by the International League Against Epilepsy: position paper of the ILAE commission for classification and terminology","volume":"58","author":"Fisher RS","year":"2017","unstructured":"Fisher RS, Cross JH, French JA, et al.. Operational classification of seizure types by the International League Against Epilepsy: position paper of the ILAE commission for classification and terminology. Epilepsia. 2017, 58:522-30. 10.1111\/epi.13670","journal-title":"Epilepsia"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3988\/jcn.2016.12.4.434","article-title":"Estimating the prevalence of treated epilepsy using administrative health data and its validity: ESSENCE study","volume":"12","author":"Lee SY","year":"2016","unstructured":"Lee SY, Chung SE, Kim DW, et al.. Estimating the prevalence of treated epilepsy using administrative health data and its validity: ESSENCE study. J Clin Neurol. 2016, 12:434-40. 10.3988\/jcn.2016.12.4.434","journal-title":"J Clin Neurol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2018.00845","article-title":"The epidemiological characteristics of epilepsy in the province of Khyber Pakhtunkhwa, Pakistan","volume":"9","author":"Ullah S","year":"2018","unstructured":"Ullah S, Ali N, Khan A, Ali S, Nazish HR. The epidemiological characteristics of epilepsy in the province of Khyber Pakhtunkhwa, Pakistan. Front Neurol. 2018, 9:845. 10.3389\/fneur.2018.00845","journal-title":"Front Neurol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.20431\/2456-057X.0301003","article-title":"Awareness and prevalence of epilepsy; a study in educational hubs at Sheringal, Khyber Pakhtunkhwa, Pakistan.","volume":"6","author":"Akhter N","year":"2018","unstructured":"Akhter N, Kamal Z, Rahman FU, Sultana P, Durrani Z. . Awareness and prevalence of epilepsy; a study in educational hubs at Sheringal, Khyber Pakhtunkhwa, Pakistan.. ARC Journal of Neuroscience. 2018, 6:9-20. 10.20431\/2456-057X.0301003","journal-title":"ARC Journal of Neuroscience"},{"key":"ref8","article-title":"Prevalence, treatment approaches and role of medicinal plants towards epilepsy","volume":"63","author":"Tehmina","year":"2020","unstructured":"Tehmina, Ali S, Shira G, Hassan S, Shamsun N, Bano Z, Kiran C. Prevalence, treatment approaches and role of medicinal plants towards epilepsy. Hamdard Medicus. 2020, 63:13-8.","journal-title":"Hamdard Medicus"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.12793\/tcp.2021.29.e1","article-title":"A meta-analysis: efficacy and safety of anti-epileptic drugs prescribed in Korea as monotherapy and adjunctive treatment for patients with focal epilepsy","volume":"29","author":"Jeon J","year":"2021","unstructured":"Jeon J, Oh J, Yu KS. A meta-analysis: efficacy and safety of anti-epileptic drugs prescribed in Korea as monotherapy and adjunctive treatment for patients with focal epilepsy. Transl Clin Pharmacol. 2021, 29:6-20. 10.12793\/tcp.2021.29.e1","journal-title":"Transl Clin Pharmacol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2014.17426","article-title":"Resective epilepsy surgery for drug-resistant focal epilepsy: a review","volume":"313","author":"Jobst BC","year":"2015","unstructured":"Jobst BC, Cascino GD. Resective epilepsy surgery for drug-resistant focal epilepsy: a review. JAMA. 2015, 313:285-93. 10.1001\/jama.2014.17426","journal-title":"JAMA"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1684\/epd.2014.0720","article-title":"Concept of epilepsy surgery and presurgical evaluation","volume":"17","author":"Rathore C","year":"2015","unstructured":"Rathore C, Radhakrishnan K. Concept of epilepsy surgery and presurgical evaluation. Epileptic Disord. 2015, 17:19-31. 10.1684\/epd.2014.0720","journal-title":"Epileptic Disord"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.33588\/rn.6701.2018015","article-title":"Patients' perceptions of and attitudes towards epilepsy surgery: mistaken concepts in Colombia [Article in Spanish]","volume":"67","author":"Ladino LD","year":"20181","unstructured":"Ladino LD, Benjumea-Cuartas V, Diaz-Marin DM, et al.. Patients' perceptions of and attitudes towards epilepsy surgery: mistaken concepts in Colombia [Article in Spanish] . Rev Neurol. 20181, 67:6-14. 10.33588\/rn.6701.2018015","journal-title":"Rev Neurol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3904\/kjim.2016.195","article-title":"An overview of meta-analysis for clinicians","volume":"33","author":"Lee YH","year":"2018","unstructured":"Lee YH. An overview of meta-analysis for clinicians. Korean J Intern Med. 2018, 33:277-83. 10.3904\/kjim.2016.195","journal-title":"Korean J Intern Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000005755","article-title":"Practice guideline update summary: efficacy and tolerability of the new antiepileptic drugs I: treatment of new-onset epilepsy: report of the guideline development, dissemination, and implementation subcommittee of the American Academy of Neurology and the American Epilepsy Society","volume":"91","author":"Kanner AM","year":"2018","unstructured":"Kanner AM, Ashman E, Gloss D, et al.. Practice guideline update summary: efficacy and tolerability of the new antiepileptic drugs I: treatment of new-onset epilepsy: report of the guideline development, dissemination, and implementation subcommittee of the American Academy of Neurology and the American Epilepsy Society. Neurology. 2018, 91:74-81. 10.1212\/WNL.0000000000005755","journal-title":"Neurology"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2016.11.018","article-title":"Epilepsy treatment in adults and adolescents: expert opinion, 2016","volume":"69","author":"Shih JJ","year":"2017","unstructured":"Shih JJ, Whitlock JB, Chimato N, Vargas E, Karceski SC, Frank RD. Epilepsy treatment in adults and adolescents: expert opinion, 2016. Epilepsy Behav. 2017, 69:186-222. 10.1016\/j.yebeh.2016.11.018","journal-title":"Epilepsy Behav"},{"key":"ref16","article-title":"Epilepsies: diagnosis and management","year":"2021","unstructured":"Epilepsies. diagnosis and management. NICE Clinical Guidelines, No. 137. National Institute for Health and Care Excellence (NICE), London; 2021."},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2011.04.064","article-title":"Binding characteristics of brivaracetam, a selective, high affinity SV2A ligand in rat, mouse and human brain: relationship to anti-convulsant properties","volume":"664","author":"Gillard M","year":"2011","unstructured":"Gillard M, Fuks B, Leclercq K, Matagne A. Binding characteristics of brivaracetam, a selective, high affinity SV2A ligand in rat, mouse and human brain: relationship to anti-convulsant properties. Eur J Pharmacol. 2011, 664:36-44. 10.1016\/j.ejphar.2011.04.064","journal-title":"Eur J Pharmacol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1038\/bjp.2008.198","article-title":"Anti-convulsive and anti-epileptic properties of brivaracetam (ucb 34714), a high-affinity ligand for the synaptic vesicle protein, SV2A","volume":"154","author":"Matagne A","year":"2008","unstructured":"Matagne A, Margineanu DG, Kenda B, Michel P, Klitgaard H. Anti-convulsive and anti-epileptic properties of brivaracetam (ucb 34714), a high-affinity ligand for the synaptic vesicle protein, SV2A. Br J Pharmacol. 2008, 154:1662-71. 10.1038\/bjp.2008.198","journal-title":"Br J Pharmacol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.2147\/CPAA.S114072","article-title":"A review of the pharmacology and clinical efficacy of brivaracetam","volume":"10","author":"Klein P","year":"2018","unstructured":"Klein P, Diaz A, Gasalla T, Whitesides J. A review of the pharmacology and clinical efficacy of brivaracetam. Clin Pharmacol. 2018, 10:1-22. 10.2147\/CPAA.S114072","journal-title":"Clin Pharmacol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011501.pub3","article-title":"Brivaracetam add-on therapy for drug-resistant epilepsy","volume":"3","author":"Bresnahan R","year":"2022","unstructured":"Bresnahan R, Panebianco M, Marson AG. Brivaracetam add-on therapy for drug-resistant epilepsy. Cochrane Database Syst Rev. 2022, 3:CD011501. 10.1002\/14651858.CD011501.pub3","journal-title":"Cochrane Database Syst Rev"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.2147\/NDT.S143548","article-title":"Brivaracetam in the treatment of epilepsy: a review of clinical trial data","volume":"15","author":"Feyissa AM","year":"2019","unstructured":"Feyissa AM. Brivaracetam in the treatment of epilepsy: a review of clinical trial data. Neuropsychiatr Dis Treat. 2019, 15:2587-600. 10.2147\/NDT.S143548","journal-title":"Neuropsychiatr Dis Treat"},{"key":"ref22","article-title":"Briviact (Brivaracetam) US Prescribing Information","year":"2023","unstructured":"Briviact (Brivaracetam) US Prescribing Information. UCB, Inc., Smyrna, GA; 2023."},{"key":"ref23","article-title":"Summary of Product Characteristics","year":"2019","unstructured":"Summary of Product Characteristics. UCB Pharma SA, Braine-l\u2019Alleud, Belgium; 2019."},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.2174\/157015909788848866","article-title":"Antiepileptic drug monotherapy: the initial approach in epilepsy management","volume":"7","author":"St Louis EK","year":"2009","unstructured":"St Louis EK, Rosenfeld WE, Bramley T. Antiepileptic drug monotherapy: the initial approach in epilepsy management. Curr Neuropharmacol. 2009, 7:77-82. 10.2174\/157015909788848866","journal-title":"Curr Neuropharmacol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1111\/epi.13416","article-title":"Safety, tolerability, and seizure control during long-term treatment with adjunctive brivaracetam for partial-onset seizures","volume":"57","author":"Toledo M","year":"2016","unstructured":"Toledo M, Whitesides J, Schiemann J, et al.. Safety, tolerability, and seizure control during long-term treatment with adjunctive brivaracetam for partial-onset seizures. Epilepsia. 2016, 57:1139-51. 10.1111\/epi.13416","journal-title":"Epilepsia"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1111\/epi.12391","article-title":"Adjunctive brivaracetam for uncontrolled focal and generalized epilepsies: results of a phase III, double-blind, randomized, placebo-controlled, flexible-dose trial","volume":"55","author":"Kwan P","year":"2014","unstructured":"Kwan P, Trinka E, Van Paesschen W, Rektor I, Johnson ME, Lu S. Adjunctive brivaracetam for uncontrolled focal and generalized epilepsies: results of a phase III, double-blind, randomized, placebo-controlled, flexible-dose trial. Epilepsia. 2014, 55:38-46. 10.1111\/epi.12391","journal-title":"Epilepsia"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1111\/epi.13275","article-title":"Brivaracetam in Unverricht-Lundborg disease (EPM1): results from two randomized, double-blind, placebo-controlled studies","volume":"57","author":"K\u00e4lvi\u00e4inen R","year":"2016","unstructured":"K\u00e4lvi\u00e4inen R, Genton P, Andermann E, et al.. Brivaracetam in Unverricht-Lundborg disease (EPM1): results from two randomized, double-blind, placebo-controlled studies. Epilepsia. 2016, 57:210-21. 10.1111\/epi.13275","journal-title":"Epilepsia"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1167.2008.01546.x","article-title":"Clinical picture of EPM1-Unverricht-Lundborg disease","volume":"49","author":"K\u00e4lvi\u00e4inen R","year":"2008","unstructured":"K\u00e4lvi\u00e4inen R, Khyuppenen J, Koskenkorva P, Eriksson K, Vanninen R, Mervaala E. Clinical picture of EPM1-Unverricht-Lundborg disease. Epilepsia. 2008, 49:549-56. 10.1111\/j.1528-1167.2008.01546.x","journal-title":"Epilepsia"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.62.1.23","article-title":"Systematic screening allows reduction of adverse antiepileptic drug effects: a randomized trial","volume":"13","author":"Gilliam FG","year":"2004","unstructured":"Gilliam FG, Fessler AJ, Baker G, Vahle V, Carter J, Attarian H. Systematic screening allows reduction of adverse antiepileptic drug effects: a randomized trial. Neurology. 2004, 13:23-7. 10.1212\/wnl.62.1.23","journal-title":"Neurology"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000345667.45642.61","article-title":"Adverse antiepileptic drug effects: toward a clinically and neurobiologically relevant taxonomy","volume":"72","author":"Perucca P","year":"2009","unstructured":"Perucca P, Carter J, Vahle V, Gilliam FG. Adverse antiepileptic drug effects: toward a clinically and neurobiologically relevant taxonomy. Neurology. 2009, 72:1223-9. 10.1212\/01.wnl.0000345667.45642.61","journal-title":"Neurology"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2010.09.013","article-title":"Factors contributing to Korean adolescents' perceptions of stigma with respect to epilepsy","volume":"19","author":"Rho YI","year":"2010","unstructured":"Rho YI, Lee SA, Yim SB, et al.. Factors contributing to Korean adolescents' perceptions of stigma with respect to epilepsy. Epilepsy Behav. 2010, 19:627-30. 10.1016\/j.yebeh.2010.09.013","journal-title":"Epilepsy Behav"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1016\/j.eplepsyres.2009.06.008","article-title":"Long-term outcome and determinants of quality of life after temporal lobe epilepsy surgery in adults","volume":"86","author":"Elsharkawy AE","year":"2009","unstructured":"Elsharkawy AE, May T, Thorbecke R, et al.. Long-term outcome and determinants of quality of life after temporal lobe epilepsy surgery in adults. Epilepsy Res. 2009, 86:191-9. 10.1016\/j.eplepsyres.2009.06.008","journal-title":"Epilepsy Res"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1111\/ane.13257","article-title":"Seizure freedom as an outcome in epilepsy treatment clinical trials","volume":"142","author":"Halford JJ","year":"2020","unstructured":"Halford JJ, Edwards JC. Seizure freedom as an outcome in epilepsy treatment clinical trials. Acta Neurol Scand. 2020, 142:91-107. 10.1111\/ane.13257","journal-title":"Acta Neurol Scand"},{"key":"ref34","article-title":"The epilepsies","year":"2012","unstructured":"The epilepsies. The Diagnosis and Management of the Epilepsies in Adults and Children in Primary and Secondary Care. Pharmacological Update of Clinical Guideline 20; NICE Clinical Guidelines, No. 137.  Royal College of Physicians, London, UK; 2012."},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1177\/2050312118772471","article-title":"Patient reported adverse events among epileptic patients taking antiepileptic drugs","volume":"6","author":"Ayalew MB","year":"2018","unstructured":"Ayalew MB, Muche EA. Patient reported adverse events among epileptic patients taking antiepileptic drugs. SAGE Open Med. 2018, 6:2050312118772471. 10.1177\/2050312118772471","journal-title":"SAGE Open Med"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.2147\/NDT.S119030","article-title":"Drug therapy of epileptic seizures among adult epileptic outpatients of University of Gondar Referral and Teaching Hospital, Gondar, North West Ethiopia","volume":"12","author":"Birru EM","year":"2016","unstructured":"Birru EM, Shafi M, Geta M. Drug therapy of epileptic seizures among adult epileptic outpatients of University of Gondar Referral and Teaching Hospital, Gondar, North West Ethiopia. Neuropsychiatr Dis Treat. 2016, 12:3213-9. 10.2147\/NDT.S119030","journal-title":"Neuropsychiatr Dis Treat"},{"key":"ref37","article-title":"Drug use evaluation of antiepileptic drugs in outpatient epilepsy clinic of Bishoft General Hospital, East Shoa, Ethiopia","volume":"5","author":"Rishe W","year":"2015","unstructured":"Rishe W, Seifu MF, Gelaw BK, Gunasekaran T, Gebremariam ET, Mohammed MA. Drug use evaluation of antiepileptic drugs in outpatient epilepsy clinic of Bishoft General Hospital, East Shoa, Ethiopia. Indo Am J Pharm Res. 2015, 5:951-62.","journal-title":"Indo Am J Pharm Res"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/3189108","article-title":"Antiepileptic drug nonadherence and its predictors among people with epilepsy","volume":"2016","author":"Getnet A","year":"2016","unstructured":"Getnet A, Woldeyohannes SM, Bekana L, et al.. Antiepileptic drug nonadherence and its predictors among people with epilepsy. Behav Neurol. 2016, 2016:3189108. 10.1155\/2016\/3189108","journal-title":"Behav Neurol"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2019-030746","article-title":"First clinical postmarketing experiences in the treatment of epilepsies with brivaracetam: a retrospective observational multicentre study","volume":"9","author":"Menzler K","year":"2019","unstructured":"Menzler K, Mross PM, Rosenow F, et al.. First clinical postmarketing experiences in the treatment of epilepsies with brivaracetam: a retrospective observational multicentre study. BMJ Open. 2019, 9:e030746. 10.1136\/bmjopen-2019-030746","journal-title":"BMJ Open"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1111\/ane.13287","article-title":"Time course of 75%-100% efficacy response of adjunctive brivaracetam","volume":"142","author":"Klein P","year":"2020","unstructured":"Klein P, Laloyaux C, Elmoufti S, Gasalla T, Martin MS. Time course of 75%-100% efficacy response of adjunctive brivaracetam. Acta Neurol Scand. 2020, 142:175-80. 10.1111\/ane.13287","journal-title":"Acta Neurol Scand"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1111\/epi.13631","article-title":"Time to onset of sustained \u226550% responder status in patients with focal (partial-onset) seizures in three phase III studies of adjunctive brivaracetam treatment","volume":"58","author":"Klein P","year":"2017","unstructured":"Klein P, Johnson ME, Schiemann J, Whitesides J. Time to onset of sustained \u226550% responder status in patients with focal (partial-onset) seizures in three phase III studies of adjunctive brivaracetam treatment. Epilepsia. 2017, 58:e21-5. 10.1111\/epi.13631","journal-title":"Epilepsia"},{"key":"ref42","article-title":"Subjectively perceived side-effects of anti-epileptic drugs in chronic refractory epilepsy","volume":"4","author":"Ijff DM","year":"2015","unstructured":"Ijff DM, de Kinderen RJ, Vader CI, Majoie MH, Aldenkamp AP. Subjectively perceived side-effects of anti-epileptic drugs in chronic refractory epilepsy. Adv Pharmacoepidemiol Drug. 2015, 4:186.","journal-title":"Adv Pharmacoepidemiol Drug"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/208268-efficacy-and-safety-of-brivaracetam-in-persons-with-epilepsy-in-a-real-world-setting-a-prospective-non-interventional-study","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:08:29Z","timestamp":1707509309000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/208268-efficacy-and-safety-of-brivaracetam-in-persons-with-epilepsy-in-a-real-world-setting-a-prospective-non-interventional-study"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,11]]},"references-count":42,"URL":"https:\/\/doi.org\/10.7759\/cureus.50313","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12,11]]}}}